A Peninsula biotech company focusing on a deadly lung-scarring disease lost more than half its stock value Monday after ...

After a year of dwindling coffers and repeated layoff rounds, the Southern California biotech firm Viracta Therapeutics has ...

One of Cincinnati’s best-funded startups further cemented its place on that list last year.

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

Houston-based Moleculin Biotech, Inc., currently trading at $0.80 and showing a market capitalization of $2.4 million, has entered into an agreement with an investor to modify certain terms of ...

Axsome settles Auvelity patent litigation with Teva, delaying a generic launch until 2038. Analysts see growth potential with Symbravo's migraine approval.

WASHINGTON — The Mexican government repealed its ban on biotech corn imports from the United States. The Feb. 6 move lined up ...

Strategic investments support vertical farming technology and fuel growth HAMILTON, OHIO / ACCESS Newswire / February 10, ...

"I would like to extend a warm welcome to Dan Kirby on behalf of the entire Iovance team,” stated Frederick Vogt, Ph.D., J.D., Interim President, Chief Executive Officer and board member of Iovance.

Budget emphasizes self-reliance in pulses, with a Rs 1,000 crore investment in hybrid technology and climate-resilient crops.

While foreign investors have been reducing their exposure to Indian pharma, some leading domestic institutional investors ...

Biotech startup NovoNutrients has found a way to create an alternative protein that can be used in human and pet food.